72.11.Z - Scientific research and development activities
20.13.Z - Manufacture of other inorganic basic chemicals
20.14.Z - Manufacture of other organic basic chemicals
20.59.Z - Manufacture of other chemical products, not elsewhere classified
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.19.Z - Activity of agents involved in wholesale trade of non-specialized goods
46.90.Z - Non-specialized wholesale trade
71.20.B - Inspection and issuing opinions on the technical condition of chimneys and ventilation ducts
72.19.Z - Scientific research and development activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0 | 0 | 0 | 80 |
EBITDA | 0 | 0 | 0 | 54,6 |
Short time liabilities | 0 | 0 | 0 | 1,4 |
Equity capital | 0 | 0 | 0 | 28,2 |
Operating profit (EBIT) | 0 | 0 | 0 | 76,7 |
Assets | 0,1 | 0,1 | 0,1 | 4,1 |
Net profit (loss) | 0 | 0 | 0 | 71,6 |
Cash | 0 | 0 | 0 | 77 |
Net income from sale | 0,1 | 0,1 | 0,1 | 12,2 |
Liabilities and provisions for liabilities | 0 | 0 | 0 | -11,7 |
Working assets | 0 | 0 | 0 | 13,7 |
Depreciation | 0 | 0 | 0 | 14,5 |
% | % | % | p.p. | |
Profitability of capital | 26,3 | 39,4 | 52,7 | 13,3 |
Equity capital to total assets | 38,6 | 39,8 | 48,9 | 9,1 |
Gross profit margin | 9,1 | 13,4 | 21,4 | 8 |
EBITDA Margin | 17,5 | 21,5 | 29,6 | 8,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 108 | 82 | 74 | -8 |
Current financial liquidity indicator | 1.5208450555801392 | 1.308223009109497 | 1.5055192708969116 | 0,2 |
Net dept to EBITDA | 1.1167097091674805 | 1.1746753454208374 | 0.47726374864578247 | -0,7 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane